The Romanian state must allow companies to make a profit in order to attract investments, said Paos Alexakos, director for Central and Eastern Europe at Swiss group Novartis Pharmaceuticals, according to Mediafax.

“We have invested and we will continue to invest in Romania. We are producing drugs for 16 markets here, but it’s disappointing that there is no innovation on the market,” Alexakos said.

Novartis has invested EUR 40 million in Romania, in its Sandoz antibiotics factory in Targu-Mures and plans EUR 13 million new investments to double the capacity of the factory. However, the group’s representatives say that Romania is less competitive than other countries in the region. “We hope that things will change. Authorities tell us this all the time,” Alexakos added.

editor@romania-insider.com